Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Marine MaurelFrancisco PozoGloria Pérez-GimenoSilke BudaNoémie SèveBeatrix OrosziMariette HooiveldVerónica GomezLisa DomeganIván Martínez-BazMaja IlićAnna Sara CarnahanMaria Elena MihaiAna MartínezLuise GoerlitzVincent EnoufJudit Krisztina HorváthFrederika DijkstraAna Paula RodriguesCharlene BennettCamino Trobajo-SanmartínIvan MlinarićNeus Latorre-MargalefAlina IvanciucAurora LopezRalf DürrwaldAlessandra FalchiGergő TúriAdam MeijerAryse MeloJoan O'DonnellJesús CastillaVesna Višekruna VučinaTove Samuelsson HageyMihaela LazarMarlena KaczmarekSabrina BacciEsther Kisslingnull nullPublished in: Influenza and other respiratory viruses (2024)
The 2022-2023 end-of-season results from the VEBIS network at primary care level showed high VE among children and against influenza B, with lower VE against influenza A(H1N1)pdm09 and A(H3N2).